NASDAQ : DSGN

Design Therapeutics, Inc. — Earnings Estimates

$13.57 USD

$0.37 (2.8%)

Volume
443.14K
Average Volume
959.17K
Market Capitalization
$847.54M
P/E Ratio
-11.50
Dividend Yield
0.00%
Price Target
$20.50
Year High
$17.25
Year Low
$3.95
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$18.86

Annual earnings financials

DSGN financial data with annual/quarterly toggle

DSGN GAAP EPS - Annual & Quarterly

DSGN Sales Revenue - Annual & Quarterly

DSGN Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

DSGN Estimated and Actual Revenue by Quarter
DSGN Estimated and Actual EPS by Quarter
DSGN Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2030-12-30 1 - - - - - -
2030-09-30 1 - - - - - -
2030-06-30 1 - - - - - -
2030-03-30 1 - - - - - -
2029-12-30 1 - - - - - -
2029-09-30 1 - - - - - -
DSGN Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2030-12-30 1 26.88M 26.88M 26.88M - - -
2030-09-30 1 18.13M 18.13M 18.13M - - -
2030-06-30 1 6.88M 6.88M 6.88M - - -
2030-03-30 1 -9.38M -9.38M -9.38M - - -
2029-12-30 1 -11.25M -11.25M -11.25M - - -
2029-09-30 1 -15.63M -15.63M -15.63M - - -
DSGN Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2030-12-30 1 37M 37M 37M 4 0.43 0.43 0.43
2030-09-30 1 28M 28M 28M 5 0.29 0.29 0.29
2030-06-30 1 19M 19M 19M 2 0.11 0.11 0.11
2030-03-30 1 13M 13M 13M 2 -0.15 -0.15 -0.15
2029-12-30 1 8M 8M 8M 2 -0.18 -0.18 -0.18
2029-09-30 1 4M 4M 4M 2 -0.25 -0.25 -0.25